Mahzi Therapeutics Inc.

CIK 1888808 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mahzi Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Jun 17, 2026C0001888808-26-000001
Jul 8, 2024D/A0001888808-24-000001
Nov 14, 2022D/A0001888808-22-000002
Oct 21, 2021D0001888808-21-000001